The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHipgnosis Song. Regulatory News (SONG)

Share Price Information for Hipgnosis Song. (SONG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 102.00
Bid: 102.00
Ask: 102.20
Change: -2.60 (-2.49%)
Spread: 0.20 (0.196%)
Open: 102.80
High: 102.80
Low: 101.80
Prev. Close: 104.60
SONG Live PriceLast checked at -
Hipgnosis Songs is an Investment Trust

To provide shareholders with an attractive and growing level of income, together with the potential for capital growth, from investment in songs and associated musical intellectual property rights.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on dividend intentions

6 Nov 2023 07:00

RNS Number : 4168S
Hipgnosis Songs Fund Limited
06 November 2023
 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation.

 

LEI: 213800XJIPNDVKXMOC11

 

 

Hipgnosis Songs Fund Limited ("Hipgnosis" or the "Company")

 

Update on Dividend Intentions

6 November 2023 

 

The Board of Hipgnosis Songs Fund Limited together with its Investment Adviser, Hipgnosis Song Management Limited, have been undertaking a review of the Company's financial position as a result of which the Board has determined that it will not declare dividends before the new financial year.

As a result of this review:

· It has been determined that the Catalogue bonus provision is expected to increase by approximately $23 million to $68 million at 30 September 2023 as there are now ten (31 March 2023: six) out of the Company's 146 Catalogues likely to meet performance hurdles as defined in their acquisition agreements. The $68 million would be payable over a period of three years from 30 September 2023, with $40 million due within 12 months, $24 million due within 1-2 years and $4 million due within 2-3 years. In addition, there are a further nineteen Catalogues with active bonus provisions totalling $75 million, that are unlikely to meet performance hurdles; these are not recognised as provisions but are contingent liabilities and will be disclosed in the forthcoming interim results with associated sensitivity analysis.

 

· The Board, advised by the Investment Adviser, is exploring refinements to the methodology adopted in the Company's revenue accrual estimation process for the year end results which, based on early assessments, may result in an accrual adjustment reducing revenue accruals by up to 10%. Any changes would aim to bring consistency to the description of IFRS revenue and the Pro Forma Annual Revenue measure through the use of granular data in the underlying calculations, to support an improved estimation process and enhanced disclosures.

 

 

In light of this information, the Board has determined that it will not declare dividends before the new financial year. The operating cash flow of the Company during this time will therefore be used to ensure that the Company has sufficient cash resources to fund the payment of the Catalogue bonuses as required. Additionally, the suspension of dividend payments will provide the Company with the headroom required to maintain compliance with its revolving credit facility's Fixed Charge Cover Ratio covenant if the accrual adjustment is realised in full.

The Board will update the Company's dividend policy as part of proposals which are due to be made to shareholders by 26 April 2024 following completion of the Strategic Review.

The person responsible for making this notification is Sylvia Coleman, Senior Independent Director of Hipgnosis Songs Fund Limited.

 

 

For further information please contact:

 

Hipgnosis Songs Fund Limited

Sylvia Coleman

via Singer Capital Markets

+44 (0) 20 7496 3000

Hipgnosis Song Management

Merck Mercuriadis

Ben Katovsky

Giles Croot (Media)

+44 (0) 20 4542 1530

+44 (0) 20 4542 1511

Headland Consultancy - Financial PR

Susanna Voyle / Charlie Twigg

 

+44 (0) 20 3805 4822

J.P. Morgan Cazenove - Sponsor, Financial Adviser and Corporate Broker

William Simmonds / Jérémie Birnbaum (Corporate Finance)

+44 (0) 20 3493 8000

Singer Capital Markets - Corporate Broker

James Moat / Angus Campbell (Corporate Finance)

Alan Geeves / James Waterlow / Sam Greatrex (Sales) 

+44 (0) 20 7496 3000

RBC Capital Markets - Corporate Broker

Elliot Thomas / Max Avison (Corporate Finance)

 

+44 (0) 20 7635 4000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVEAAFSEDADFAA
Date   Source Headline
10th Feb 20213:36 pmRNSDirector/PDMR Shareholding
5th Feb 20214:26 pmRNSSuccessful Fundraise & Result of EGM
21st Jan 20214:44 pmRNSPublication of Prospectus
21st Jan 20217:00 amRNSLaunch of Issue & Dividend Declaration
21st Jan 20217:00 amRNSAcquisition of Music Catalogue
13th Jan 20217:00 amRNSAcquisition of Music Catalogue
6th Jan 20212:58 pmRNSIncreased Debt Facility
6th Jan 20217:00 amRNSAcquisition of Music Catalogue
5th Jan 20217:00 amRNSAcquisition of Music Catalogue
4th Jan 20217:00 amRNSAcquisition of Music Catalogue
4th Jan 20217:00 amRNSTotal Voting Rights
15th Dec 20201:09 pmRNSHolding(s) in Company
14th Dec 20202:25 pmRNSDirector/PDMR Shareholding
14th Dec 20208:33 amRNSMariah Carey Reaches UK Number 1
14th Dec 20207:00 amRNSMariah Carey Reaches UK Number 1
4th Dec 20207:00 amRNSContemplation of Equity Raise
4th Dec 20207:00 amRNSInterim Results
1st Dec 20205:30 pmRNSHipgnosis Songs Fund
30th Nov 20207:00 amRNSNet Asset Value and C Share Conversion Ratio
13th Nov 20207:00 amRNSAcquisition of Music Catalogue
2nd Nov 20207:00 amRNSAcquisition of Portfolio of Catalogues
28th Oct 20207:00 amRNSDividend Declaration
21st Oct 20205:42 pmRNSDirector/PDMR Shareholding
14th Oct 20207:00 amRNSAdvisory Board Appointment & Catalogue Acquisition
2nd Oct 20203:34 pmRNSHolding(s) in Company
1st Oct 20204:11 pmRNSDirector/PDMR Shareholding
1st Oct 20207:00 amRNSTotal Voting Rights
24th Sep 20203:01 pmRNSResult of Equity Issue
21st Sep 20207:01 amRNSRetail Offer
21st Sep 20207:00 amRNSProposed Placing
17th Sep 20207:00 amRNSAppointment of Joint Broker
15th Sep 202010:16 amRNSHolding(s) in Company
14th Sep 20203:30 pmRNSHolding(s) in Company
11th Sep 20207:01 amRNSCapital Markets Day
11th Sep 20207:01 amRNSAcquisition of Music Catalogues
10th Sep 20207:00 amRNSAcquisition of Big Deal Music
9th Sep 20207:00 amRNSConversion of C Shares & Update to Dividend Target
8th Sep 20204:52 pmRNSResult of AGM
8th Sep 20207:00 amRNSAppointment of Ted Cockle and Amy Thomson
3rd Sep 20207:00 amRNSNotice of Capital Markets Day
1st Sep 20207:00 amRNSAcquisition of Music Catalogue
24th Aug 20207:00 amRNSAcquisition of Music Catalogue
13th Aug 20204:07 pmRNSDirector/PDMR Shareholding
13th Aug 20207:00 amRNSAcquisition of Music Catalogue
11th Aug 20204:44 pmRNSNotice of AGM
5th Aug 20207:00 amRNSAcquisition of Music Catalogue
3rd Aug 20207:00 amRNSTotal Voting Rights
3rd Aug 20207:00 amRNSAcquisition of Music Catalogue
29th Jul 20207:00 amRNSAcquisition of Music Catalogue
27th Jul 20203:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.